Compare LRE & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRE | NXPL |
|---|---|---|
| Founded | 2001 | 1997 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | | Telecommunications Equipment |
| Sector | | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 19.2M |
| IPO Year | 2022 | N/A |
| Metric | LRE | NXPL |
|---|---|---|
| Price | $1.38 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.5K | ★ 394.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.43 |
| 52 Week High | $2.86 | $1.11 |
| Indicator | LRE | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 37.42 |
| Support Level | $1.34 | N/A |
| Resistance Level | $1.57 | $0.72 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 47.06 | 24.48 |
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.